Adductor Canal Block Versus Lumbar Plexus Block for Post Operative Pain Management After Total Knee Replacement

Cairo University (CU)

Status: Unknown

Conditions: Pain Management

Treatments: Procedure: Ultrasound-guided Lumber Plexus Block; Procedure: adductor canal block

Study type: Interventional

Funder types: Other

Identifiers

NCT02853669

adductor canal

Details and patient eligibility

About

Adductor canal block (ACB), Saphenous nerve block, which is a block of a purely sensory nerve which shares in nerve supply of knee joint has a hypothetical advantage of better pain management with less motor affection. Also, it has a clear anatomical landmark that will increase the success rate (femoral artery) (*).On the other hand, being a branch of the femoral nerve and far distal from the plexus, this can decrease the blocking effectiveness. Likewise, the great variation of the knee nerve supply.

This prospective double-blinded randomized controlled trial is comparing ultrasound guided adductor canal block (ACB) versus ultrasound-guided lumbar plexus block (LPB) in patients undergoing total knee arthroplasty aiming at decreasing post-operative pain, helping in early mobilization and better physiotherapy.

This study hypothesizes that ACB, compared with LPB, will exhibit less motor, weakness, fewer opioids consumption with the same or better pain score.

Full description

This prospective double-blinded randomized controlled trial is comparing ultrasound guided adductor canal block (ACB) versus ultrasound-guided lumbar plexus block (LPB) in patients undergoing total knee arthroplasty aiming at decreasing post-operative pain, helping in early mobilization and better physiotherapy.

This study hypothesizes that ACB, compared with LPB, will exhibit less motor, weakness, fewer opioids consumption with the same or better pain score.

Enrollment: 26 estimated patients

Sex: All

Ages: 35 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA I-II
• Age more than 25 and less than 80 were included

Exclusion criteria

• Patients with known allergy to the medications to be given
• ASA III, IV
• Age less than 25 or more than 80
• Dementia
• Deafness
• Psychological disease
• Difficult to communicate
• Cannot lay flat
• INR more than 1.5
• Low platelets (less than 100000/ml3) or with significant coagulopathy

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

26 participants in 2 patient groups

group (A) lumber plexus block

Experimental group

Description:

Ultrasound-guided Lumber plexus Block (30 cc of 0.25% of bupivacaine, via a 22-gauge 2-inch Stimuplex A needle) with nerve stimulator confirmation.

Treatment:

Procedure: Ultrasound-guided Lumber Plexus Block

Group (B) adductor canal block

Experimental group

Description:

ultrasound-guided Adductor Canal Block (15 cc of 0.5% of bupivacaine)

Treatment:

Procedure: adductor canal block